Dr. Conway et al reply

We thank Sauret et al for their interest in our systematic literature review that explored potential diagnostic confusion between giant cell arteritis (GCA) and the coronavirus disease 2019 (COVID-19). This was a particularly important consideration during the early months of the COVID-19 pandemic, when community testing for SARS-CoV-2 was limited and diagnostic tests for GCA were restricted or unavailable due to redeployment of staff.</p

Dr. Conway et al reply

We thank Sauret et al for their interest in our systematic literature review that explored potential diagnostic confusion between giant cell arteritis (GCA) and the coronavirus disease 2019 (COVID-19). This was a particularly important consideration during the early months of the COVID-19 pandemic, when community testing for SARS-CoV-2 was limited and diagnostic tests for GCA were restricted or unavailable due to redeployment of staff.</p

Giant Cell Arteritis and COVID-19:Similarities and Discriminators. A Systematic Literature Review

OBJECTIVE: To identify shared and distinct features of giant cell arteritis (GCA) and coronavirus disease 2019(COVID-19) to reduce diagnostic errors that could cause delays in correct treatment. METHODS: Two systematic literature reviews determined the frequency of clinical features of GCA and COVID-19 in published reports. Frequencies in each disease were summarized using medians and ranges. RESULTS: Headache was common in GCA but was also observed in COVID-19 (GCA 66%, COVID-19 10%). Jaw claudication or visual loss (43% and 26% in GCA, respectively) generally were not reported in COVID-19. Both diseases featured fatigue (GCA 38%, COVID-19 43%) and elevated inflammatory markers (C-reactive protein [CRP] elevated in 100% of GCA, 66% of COVID-19), but platelet count was elevated in 47% of GCA but only 4% of COVID-19 cases. Cough and fever were commonly reported in COVID-19 and less frequently in GCA (cough, 63% for COVID-19 vs 12% for GCA; fever, 83% for COVID-19 vs 27% for GCA). Gastrointestinal upset was occasionally reported in COVID-19 (8%), rarely in GCA (4%). Lymphopenia was more common in COVID-19 than GCA (53% in COVID-19, 2% in GCA). Alteration of smell and taste have been described in GCA but their frequency is unclear. CONCLUSION: Overlapping features of GCA and COVID-19 include headache, fever, elevated CRP and cough. Jaw claudication, visual loss, platelet count and lymphocyte count may be more discriminatory. Physicians should be aware of the possibility of diagnostic confusion. We have designed a simple checklist to aid evidence-based evaluation of patients with suspected GCA

The frequency of dwarf galaxy multiples at low redshift in SDSS versus cosmological expectations

We quantify the frequency of companions of low-redshift (0.013 55 arcsec, projected separations r_p 1:4) steadily increases with decreasing Primary stellar mass, whereas the cosmological “Major Merger rate” (per Gyr) has the opposite behaviour. We conclude that cosmological simulations can be reliably used to constrain the fraction of dwarf mergers across cosmic time

Choirs, HI galaxy groups: Catalogue and detection of star-forming dwarf group members

Hα observations centred on galaxies selected from the HI Parkes All-Sky Survey (HIPASS)typically show one and sometimes two star-forming galaxies within the ~15 arcmin beam of the Parkes 64 m HI detections. In our Survey for Ionization in Neutral Gas Ga

The frequency of dwarf galaxy multiples at low redshift in SDSS versus cosmological expectations

We quantify the frequency of companions of low-redshift (0.013 55 arcsec, projected separations r_p 1:4) steadily increases with decreasing Primary stellar mass, whereas the cosmological “Major Merger rate” (per Gyr) has the opposite behaviour. We conclude that cosmological simulations can be reliably used to constrain the fraction of dwarf mergers across cosmic time